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1. Introduction 
This chapter chronicles the shift in scientific assumptions and the ensuing consensus on 
treating people with a co-occurring mental illness and a substance misuse problem. In this 
chapter, the term co-occurring disorder refers to a person with both a mental illness and a 
substance use disorder. The paradigm shift and subsequent technology transfer in the fields 
of addictions and mental health is extremely important for the lessons learned in the effort 
to integrate the two modalities. There are lessons from the process of moving new ideas 
based on science into practice. These lessons give us direction for treatment and knowledge 
transfer in the future. And, finally there is a need to examine critically the underlying flaws 
that were exposed in the philosophy and practice tradition of both models when they were 
integrated.  
Fundamentally, the attempt to develop and deliver appropriate treatment to persons with a 
co-occurring disorder illustrates one of the self-correcting mechanisms of science. 
Unchallenged, clinicians in mental health and substance abuse treatment would have had 
little motivation to examine the science underlying their practice. In the history of mental 
health and substance abuse treatment there have been few revolutionary changes in care 
and treatment that have made life better for people suffering from an addiction or mental 
illness. Based on a rapidly evolving science and a better understanding of the treatment 
needs of people with co-occurring disorders, the expectation at the turn of the 21st century 
was that by integrating the two models, effective treatment could be provided for people 
with a co-occurring disorder. 
Driven by the growing number of persons identified with a co-occurring mental health and 
substance misuse disorder the tipping point had been reached by the mid 1990s. Declared a 
crisis in the United States, the number of people being identified as having a co-occurring 
disorder was estimated to be much higher than thought. The higher rates of failure in 
treatment and repeated treatment episodes were an unnecessary burden on the treatment 
community, individuals, families of people with co-occurring disorders, and the community 
in general. In 2002, Charles G. Curie, Administrator of the Substance Abuse and Mental 
Health Services Administration (SAMHSA) announced that “addressing the needs of 
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persons with co-occurring disorders had become one of the highest priorities for the 
agency” (Center for Mental Health Services, 2004). The cost in human capital and the 
financial strain had become unacceptable. Events that followed, especially those predicated 
on the idea that the two fields of practice should be integrated, revealed a number of 
strengths and the effectiveness of some approaches; while at the same time exposing ideas 
and concepts used in both mental health and addiction treatment that are ineffective and 
harmful. 
To begin this exposition on the evolution of knowledge and services for people with a co-
occurring disorder, a brief review will examine the cause for the initial growth in awareness, 
development of consensus, and recommended treatment approaches for people with co-
occurring disorders of mental illness and addiction. In the final section of this chapter, based 
on what we learned trying to combine the two traditions, Integrated Treatment (integrated 
mental health and addiction treatment interventions) will be deconstructed and an outline 
for a third treatment technology will be proposed. This proposal will provide a way forward 
to improve treatment outcomes of people with a co-occurring disorder as well as people 
with a mental health and addiction disorder. 
Motivated by a growing awareness that people with a co-occurring disorder were being 
underserved, researchers and practitioners in the field of addictionology and mental health 
finally received support from two major government initiatives in the late 1990s; one in 
Canada, followed shortly by a major Federal program in the United States managed by 
SAMHSA. The program in the United States was supported by an infusion of Federal grant 
money to support a number of state Co-occurring State Incentive Grant (COSIG) projects. 
The SAMHSA initiative supported integrating the two treatment models. At SAMHSA, the 
consensus was that collaboration between professionals working in mental health and 
substance misuse treatment using their different approaches and interventions would 
complement each other and produce better outcomes for people treated for a co-occurring 
disorder. Instead, the effort to integrate the two treatment systems revealed flaws in 
philosophy and concepts in both models that are incompatible and ineffective. 
2. A growing consensus 
By the late 1970s, clinicians working in the mental health and substance abuse treatment 
communities were reporting anecdotal evidence of a large number of people who had both 
a mental illness and an addiction disorder. As research evidence accumulated, concern grew 
among policy makers, program planners, clinicians and support workers. The concern about 
the high prevalence of people with co-morbid disorders focused on treatment for these 
disorders: concerns about effectiveness of the treatment, other support services needed, and 
the cost of treatment during the lifetime of an individual with a co-occurring disorder. The 
early studies supported this concern. Evidence from researchers in the field of substance 
abuse treatment declared that people being treated for an addiction were much more 
difficult to treat when they presented with depression or anxiety (McLellan & Druley, 1977; 
Ritzler, Strauss, Vanord, & Kokes, 1977). By the 1980s, practitioners and researchers in 
mental health were reporting a growing number of other mental health disorders that were 
made more difficult to treat as a result of a concurrent substance abuse problem (de Leon, 
1989).  
Two major approaches (parallel and sequential treatment) that were thought to effectively 
treat people with the co-morbid problems of mental illness and substance abuse began to 
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emerge in the mid 1980s. Although, some mental health programs were making adjustments 
in the way services were delivered to better treat people with the co-occurring problem of 
substance abuse in the early 1980s, little in the way of specific programming for people with 
a co-occurring disorder had been developed. This began to change when a New York State 
outpatient psychiatric facility in 1984 implemented various interventions from the addiction 
treatment community, typically interventions used in Treatment Communities (Sciacca, 
1991).  
The circumstances that created the pressure for these changes involved a constant drumbeat 
from practitioners and clinicians in both fields, who wanted change and who were 
challenging the scientific duality of mental illness and addiction. During the 1980s, the 
chorus of dissenters became louder. Even so, the term 'dual diagnosis' referring to people 
with the co-morbid disorders of mental illness and addiction did not appear in the subject 
index of the journal of Hospital and Community Psychiatry until 1989. Drake and colleagues, in 
1996, argued that naming the disorder was an important event. He points out that when the 
complexity of a co-occurring disorder was given a simple medical term, interest in problems 
caused by substance use among people with a mental disorder resulted in “a mandate for 
recognition and treatment” (Drake, Osher, & Bartels, 1996).  
In the 1990s, substance abuse treatment programs were reporting somewhere between 50% 
and 75% of the people they treated also had a mental health problem. At the same time, 
mental health programs reported between 20% and 50% of the people they served had a co-
occurring problem of substance use or abuse. The major treatment innovation during this 
period to accommodate people with a co-occurring disorder was from the addiction field 
where the modified Therapeutic Community (TC) for mentally ill chemical abusers was 
developed (Sacks, Sacks, De Leon, Bernhardt, & Staines, 1997). The modified TC basically 
added provisions for residents who needed to take psychotropic medication. On a positive 
note, it does give addicted people with a mental illness a safe place to stay while they 
struggled with the transition back to a life without their drug of choice to help modulate 
their mental illness.  
On the mezzo level, an important event occurred in the United States in 1999. In what Kuhn 
(1962) called a “paradigm shift,” in his seminal book, The Structure of Scientific Revolutions, a 
collaboration was established between the National Association of State Alcohol and Drug 
Abuse Directors (NASADAD) and the National Association of State Mental Health Program 
Directors (NASMHPD). Their stated purpose was to pursue scientifically based knowledge 
and treatment for people with a co-occurring disorder (NASMHPD-NASADAD, 1999). This 
national effort intended to:  “foster improvements in treatment,” “provide a classification of 
treatment settings,” “reduce the stigma associated with both disorders’” and “increase the 
acceptance of substance abuse and mental health concerns as a standard part of healthcare 
information gathering.”  
Another major push forward came from a series of SAMHSA monograms, SAMHSA’s 
Report to Congress on the Treatment and Prevention of Co-Occurring Substance Abuse and Mental 
Disorders (SAMHSA, 2002). The President’s New Freedom Commission on Mental Health Final 
Report(SAMHSA, 2003b); Co-Occurring Disorders: Integrated Dual Disorders Treatment 
Implementation Resource Kit (SAMHSA, 2003a), and Substance Abuse Treatment for Persons With 
Co-Occurring Disorders: A Treatment Improvement Protocol—TIP 42(SAMHSA, 2005); Overview 
Paper 3: Overarching Principles To Address the Needs of Persons With Co-Occurring Disorders 
(SAMHSA, 2006a). These and other SAMHSA publications have done much to fill the void 
caused by the dearth of information on people who experience a co-occurring disorder. This 
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was critical information for program planners, community developers and other decision 
makers. They were working in an environment where many states and public treatment 
facilities began trying to retool in an effort to provide more effective services for people 
admitted with a co-occurring disorder.  
In the midst of producing these publications, SAMHSA at a more systems level asked for 
and received funding from the U.S. Congress to provide Co-Occurring State Incentive 
Grants (COSIG) to support state efforts to improve treatment for people with co-occurring 
disorders seeking treatment in their state. These initiative grants provided the following 
standards for service. Treatment services provided to people with a co-occurring disorder 
are to be:  
1. consumer driven, 
2. delivered from an integrated system of care that fosters an equitable distribution of 
services, 
3. the best recovery practices available, 
4. welcoming and based on a no wrong door concept (you’re in the right place), and  
5. culturally competent. 
By the late 1990s, there was a consensus among leading experts in the fields of addiction and 
mental health treatment that sequential treatment (treatment from one provider, than 
treatment from another) or parallel treatment (treatment by two different providers at the 
same time) was not an effective and efficient model for with people with a co-occurring 
disorder (Clement et al., 1993). Instead of improving outcomes for people with a co-
occurring disorder, over time the failure rate in treatment for people with a co-occurring 
disorder remained high. Subsequent research found that sequential and parallel treatment 
tended to plunge the person seeking treatment into a vicious cycle of treatment failures 
(Flynn, 2001). These high rates of failure were discouraging to consumers, counselors, and 
the politicians who had to find a way to pay for expensive and multiple treatment episodes 
(Cherry, Dillon, Hellman & Barney, 2007).  
A consensus slowly formed around the idea that treating people for a co-occurring disorder 
using a parallel or sequential model of treatment was disjointed and ineffective. Individuals 
with complex, overlapping conditions were ill-prepared to negotiate disjointed and 
fragmented systems of care (SAMHSA, 2002). Based on his work, McGovern (2008) reported 
that as many as 50% of people with a co-occurring disorder never receive concurrent 
treatment for both disorders.”    
The implications for a failure to provide effective treatment are far-reaching. By way of an 
example, individuals with substance use and mental health disorders are highly 
overrepresented in the criminal justice system. Bureau of Justice Statistics in the United 
States report 74% of incarcerated individuals have a lifetime prevalence of substance use 
disorders and 49% report symptoms consistent with a diagnosable mental health condition. 
This is a rate that far surpasses those found in the general population (Peters, Bartoi & 
Sherman, 2008). 
2.1 The solution:  Integrative treatment 
The solution, that was proposed, was to integrate the two treatment systems of mental 
health and substance abuse (Minkoff, 1993). It was believed both problems can be dealt with 
simultaneously using an integrative approach. Minkoff suggested collaboration between 
mental health and substance abuse clinicians when treating a person with a co-occurring 
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disorder. The model is based on concomitant treatment, using the concept of treatment 
stages in treatment planning, and employing interventions derived from the fields of mental 
health and substance abuse. During the 1990’s integrated treatment continued to evolve, and 
several models of an integrated system of care were delineated (Drake & Mueser, 1996; 
Lehman & Dixon, 1995; Minkoff, 1991; Solomon, Zimberg, & Shollar, 1993).  
Even though leading experts in both fields recommend integrating the two models, there are 
vital questions that need to be asked. Is an integrative model possible?  Can these two 
traditions with their different philosophies and treatment modalities be combined 
effectively?  And, just to be on the safe side, if neither technology nor a combination of both 
technologies are effective in treating people with a co-occurring disorder—what other 
technology is available?  Before exploring these questions in more detail, it will be 
instructive to review a consensus definition of a co-occurring disorder and the numbers; the 
prevalence rate, and the demographic characteristics of people identified with a co-
occurring disorder in the United States. 
2.2 What is a co-occurring disorder 
The clinical definition of a co-occurring disorder of mental illness and addiction began to 
take form in the mid-1990s. Roughly defined as the effect of a comorbid mental illness and 
substance misuse, the effect each has  on the other was identified for the primary subgroups 
among people with a co-occurring disorder.  
Researchers and consensus panels made a number of important observations based on 
assumptions of the day (SAMHSA, 1995; Landry et al., 1991a; Lehman, Myers & Corty, 1989; 
Meyer, 1986). These researchers and practitioners concluded that behaviors related to 
substance misuse could mimic psychiatric symptoms and even psychiatric disorders. The 
effect of substance misuse on the symptomology of a mental illness had also been observed 
to be related to the type of substance used, the amount of the substance used, and the 
chronicity of substance misuse. Acute and chronic substance misuse has also been shown to 
cause a mental illness to emerge or reemerge, and to increase the severity of an existing 
mental health disorder. Withdrawal from drugs or alcohol, in some people, has also been 
observed to produce psychiatric symptoms and diagnosable psychiatric disorders. Then 
again, substance use can have a number of positive benefits for some people with a mental 
illness. For some people, drugs and alcohol helps manage, reduce and can be used to hide 
severe psychiatric symptoms.  
Among diagnosticians, mainly those who specialize in addiction assessment, psychiatric 
symptomatology (particularly mild symptoms) are often misidentified as drug-related. If a 
person presences at intake and reports any substance use in any amount, his or her 
dysfunctional and maladaptive behaviors, emotional and social problems are all too often 
attributed to alcohol and drug abuse and dependence. In the same way, a lack of 
engagement in treatment is often interpreted as an unwillingness to embrace sobriety. This 
may be an accurate analysis given a specific individual case, however, a person's treatment 
compliance and participation in a recovery program can also be affected by 
symptomatology associated with specific psychiatric diagnoses. The negative symptoms 
associated with schizophrenia, the lack of energy and interest associated with depression, 
and the fear of new situations associated with anxiety, at times, can make treatment or 
aftercare participation and compliance too stressful or distressing. The difference is that one 
interpretation blames the person; the other interpretation can be used to identify 
interventions to overcome the stress of participation in treatment. 
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In 2006, a COSIG committee was formed to forge a consensus on an operational definition of 
a person with a co-occurring disorder. An operational definition was needed so that people 
with a co-occurring disorder could be identified through screening and assessment. This 
type of definition would standardize the collection of data and provide a more accurate 
count of those being identified and treated with a co-occurring disorder. The major mistake 
with this approach for identifying the operational definition occurred when the committee 
agreed that the definition should be consistent with the conceptual underpinnings of the 
COSIG curriculum and training. This makes the definition tautological. The conceptual 
underpinning for a definition of a co-occurring disorder should be symptom and syndrome 
not an ideological construct that is a basis for curricula development and training. 
The COSIG committee proposed a broad definition and three sub definitions. The 
committee used standard Diagnostic and Statistical Manual of Mental Disorders (DSM) 
diagnostic criteria as a guide for developing their operational definition. In a broad sense, 
they suggested that a person with a co-occurring disorder is a person who meets the 
diagnostic criteria for a major Axis I Mental Disorder or Axis II Personality Disorder (a 
diagnosis not used in most of the world) and a major Substance Related Disorder. The 
criteria were fairly specific. Diagnoses of these disorders must occur simultaneously or 
within a one year time frame of each other. The figure below is a basic diagram of the co-
occurring disorder definition, revealing that a portion of this population is accounted for by 
individuals who simultaneously present with both types of disorders and is also inclusive of 
individuals who present with both disorders in a relatively close proximity (one year). 
Qualifying conditions in rendering diagnoses:  
i. Substance Dependence Disorders that meet criteria for either early or sustained 
remission can be diagnosed and will be counted toward meeting the diagnostic 
parameters of the co-occurring disorders definition. Note: Use of controlled 
environments, drug replacement therapies, or intensive therapies for abstinence 
maintenance (substance disorder remission) should not be counted in the time period 
for remission. Such instances should be diagnosed as an active disorder and will be 
counted toward meeting the diagnostic parameters of the co-occurring disorders 
definition.  
ii. Mental Health Disorders that are in remission due to the use of controlled 
environments, pharmacotherapy, or intensive psychosocial treatments should be 
diagnosed as the appropriate mental disorder that is in remission; and these disorders 
will be counted toward meeting the diagnostic parameters of the co-occurring disorders 
definition. (COSIG Clinical Protocol Committee, 2006, p.1) 
2.3 Locus of care by quadrant of severity 
Apart from specific diagnoses, when organized by severity of their mental health and 
substance abuse disorders, individuals with co-occurring disorders fall into one of four 
broad categories: 
Category I. Less severe mental disorder/less severe substance disorder. 
Category II. More severe mental disorder/less severe substance disorder. 
Category III. Less severe mental disorder/more severe substance disorder. 
Category IV. More severe mental disorder/more severe substance disorder. 
Based on the severity of an individual's co-occurring disorder, people with co-occurring 
mental health and substance abuse disorders would receive treatment in one of the 
following settings: 
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Setting for Quadrant I. Primary care physicians, community health clinics; no care. 
Setting for Quadrant II. Mental Health system (public and private). 
Setting for Quadrant III. Substance Abuse system (public and private). 
Setting for Quadrant IV. State hospitals, jails, Department of Corrections, forensic units, 
crisis facilities, and ER’s. 
Using this schema, a simplified categorization and severity of the co-occurring disorder can 
be easily matched with the locus of care and treatment. Theoretically, individuals at various 
stages of recovery from mental health and substance abuse disorders could move back and 
forth among these categories during the course of their treatment (See Figure 1). 
 
Category III 
Severe SUD, Mild MI 
Locus of Care 
Addiction Treatment 
Category IV 
Severe MI, Severe SUD 
Locus of Care 
Hospitals, Jails, ERs 
Category I 
Mild MI, Mild SUD 
Locus of Care 
Primary Health Care 
Category II 
Severe MI, Mild SUD 
Locus of Care 
Mental Health System 
Fig. 1. The Four-Quadrant Model 
3. The numbers 
Epidemiological estimates of the number of people with a co-occurring disorder of mental 
health and substance misuse have changed over time. Despite the reality that there is a lack 
of undisputed data on the number of people with co-occurring disorders, there is no dispute 
about the gravity of the situation. In part, the absence of uniform numbers is related to the 
lack of knowledge among practitioners about co-occurring disorders and the lack of a 
universally accepted definition for a co-occurring disorder. Even so, the growing body of 
epidemiological studies consistently shows that the number of people with a co-occurring 
disorder is greater than once thought.  
In the early 1990’s, the prevalence of people in the United States with a mental health 
disorder, a substance use disorder, or a co-occurring disorder was estimated to be between 
28% and 30%. This estimate was based on two epidemiologic surveys, one in the 1980’s, the 
Epidemiologic Catchment Area (ECA) study (Robins & Regier, 1991), and the other, the 
National Comorbidity Survey (NCS) conducted in the early 1990s (Kessler et al., 1994). 
These epidemiologic surveys used a standard definition of mental illness found in the 
Diagnostic and Statistical Manual of Mental Disorders (i.e., DSM-III and DSM-IIIR). These 
surveys estimated that during a one-year period, about 19% of the adults or some 38 to 40 
million people had a diagnosable mental disorder. Approximately, 3% had both a mental 
illness and an addictive disorder; and roughly 6% had an addictive disorder alone (Regier et 
al., 1993; Kessler et al., 1994).  
Studies that followed continued to add to the growing empirical data on the number of 
people needing treatment for a co-occurring disorder. Research from the substance abuse 
treatment community suggested that between 50% and 75% of the people they treated also 
had an obvious mental health problem(s). Mental health researchers studying the co-
occurring population in their treatment facilities found between 20% and 50% of the people 
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being treated had a co-occurring problem of substance abuse or dependence (Sacks, Sacks, 
De Leon, Bernhardt, & Staines, 1997). As epidemiological data from the accumulating 
studies begins to stabilize, the best estimate in the early years of the 21st century is that about 
1 in 4 adults in the United States had been diagnosed with a mental disorder, roughly 
58,000,000 people. An estimated 5 million people out of that group of individuals had a co-
occurring disorder (Kessler et al., 2005). 
These national studies also reported that approximately 50% of people with a severe mental 
health disorder are also affected by substance misuse. Furthermore, 37% of alcohol abusers 
and 53% of drug abusers have at least one serious mental illness. Among all the people 
diagnosed with a mental illness in the United States, an estimated 29% abuse alcohol and 
drugs (See Figure 2) 
 
 
Data compiled from:  Robins & Regier, 1991; Kessler et al., 1994; Kessler et al., 2005; CSAT, 2007. 
Fig. 2. Prevelance of Alcohol abusers, Drug abusers, Sever Mental Illness (SMI), and Co-
occurring disorders in the U.S. 
Among individuals with an addictive disorder that lasted at least 12 months, 42.7% reported 
at least one mental health disorder. Of those who reported a mental health disorder over the 
previous 12 months also reported at least one addictive disorder. Not surprisingly, the 
Epidemiologic Catchment Area survey found that people with a severe mental health 
disorder were at significant risk for developing a substance use disorder during their 
lifetime. For instance, 47% of people with a schizophrenic disorder also reported a substance 
misuse disorder. This percentage was over four times higher than what was found in the 
general population. Among people with a bipolar disorder, 61% had a substance misuse 
disorder. This percentage was over five times of that found in the general population. 
Overall, these studies indicate that among individuals experiencing a co-occurring disorder, 
psychiatric relapse is most often associated with the use of alcohol, marijuana, and cocaine. 
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Whereas, the most common cause for relapse among people addicted to alcohol or other 
drugs is the presence of an untreated psychiatric disorder. 
3.1 Co-occurring disorders among adolescents 
Research since the 1980s indicate that up to 80% of individuals entering publicly funded 
treatment for substance use disorders have one or more co-occurring psychiatric disorders. 
Yet only 16% of adults and 26% of adolescents have a co-occurring disorder documented in 
their intake assessments (Hills, 2007). Adolescents are another important population of 
individuals with a co-occurring disorder. Children and adolescents were ignored for the 
most part until the early 1990s. Previously, professional papers and monologues that 
describe the prevalence of children and adolescents with a co-occurring disorder were based 
on the rates, behavior, and treatment of co-occurring disorders in adults. Two major 
epidemiological studies in the early 1990s provided the initial demographic statistics on co-
occurring disorders among children and adolescents. The two epidemiological studies, The 
Epidemiological Catchment Area Study (Robins & Regier, 1991), and the National 
Comorbidity Survey (Kessler et al., 1994) reported that almost half of adolescents, who were 
not receiving treatment for a mental health or substance misuse disorder, still met DSM 
criteria for a substance use disorder and DSM criteria for at least one psychiatric disorder.  
In an epidemiological monogram published in the United States, called the New Freedom 
Commission on Mental Health (SAMHSA, 2003b), it was estimated that more than one in 
five children (21%) between the ages of 9 and 17 had a diagnosable mental health or 
substance use disorder associated with at least minimum impairment. An earlier 
investigation, the Methods for the Epidemiology of Child and Adolescent Mental Disorders 
(MECA) Study by Shaffer and associates in 1996, found that in many cases, onset of the 
disorders occurred in children as young as 7 to 11 years of age. Among children in this age 
group, an estimated 11% experienced significant emotional and behavioral problems at 
home, at school, and with peers. A smaller number of children and adolescents in this group 
(5%) experience severe mental health and substance misuse impairment (Shaffer et al., 1996).  
Institutional settings for children with a co-occurring disorder are a special case. Studies 
have shown that mental health disorders were higher than expected among children and 
adolescents who were mired in the child welfare or juvenile justice system. The best 
numbers (Putnam, 2000) suggest that between 30% and 40% of the children who were in an 
out-of-home care placement had a serious mental health disorder. In a similar institutional 
setting, an estimated 70% of children and adolescents in the juvenile justice system in the 
United States met criteria for one or more mental health disorders 
These numbers of adolescents (in these two institutional settings) with a co-occurring 
disorder indicate a major need for adolescent mental health, substance abuse, or more 
appropriately services for a co-occurring disorder. These institutions are government 
entities and agencies created and funded to care for children and adolescents who were 
removed from the supervision and care of their parents or custodian. These institutions are 
legally surrogate parents. Subsequently, the expectation is that all children in the care of 
these institutions who have a co-occurring disorder would receive at least minimal 
treatment. To the shame of the United States government, only 20% to 25 % receive mental 
health services. Even among children in these institutions who had insurance, as many as 
75% of the children still had unmet mental health service needs (Kataoka, Zhang, & Wells, 
2002).  
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Children and adolescents with substance use disorders fare no better. Use of alcohol and illicit 
drugs among children and adolescents has been estimated to be around 73% for alcohol and 
27% for illicit drugs (SAMHSA, 2003a). By 2004, estimates were suggesting that approximately 
1.4 million young people had a substance abuse problem that required treatment, but only 
10% of those needing substance abuse treatment actually received any treatment at all 
(SAMHSA Office of Applied Studies, 2005). Among adolescents in substance abuse treatment, 
more recent studies have indicated that as many as 50% to 90% can be diagnosed with a co-
occurring disorder (Reebye, Moretti, & Lessard, 1995; Roberts & Corcoran, 2005). 
For illustration purposes, findings from studies that have focused on adolescent substance 
use patterns and treatment outcomes, when mental health issues are involved, help describe 
the complex nature of these comorbid disorders. Researchers studying adolescent substance 
abuse treatment suggest that there are critical differences between an adolescent in 
substance abuse treatment with only a substance abuse problem and adolescents with a co-
occurring disorder. Children and adolescent with a co-occurring disorder tend to have an 
earlier onset of substance use, are more frequent users of substances, and can be expected to 
use substances over a longer period of time. They have increased rates of family, school, and 
legal problems than their peers, and these emotional and social relationship problems began 
at an earlier age (Libby, Orton, Stover, & Riggs, 2005; Kessler, Beglund, Demler, Jin & 
Walters, 2005; Rowe, Liddle, Greenbaum., & Henderson, 2004).    
Other studies point to the complexity of treating children and adolescents with a co-
occurring disorder at a substance abuse treatment program. These studies report that 
children and adolescents with a co-occurring disorder are significantly more likely to drop 
out of substance abuse treatment and have a poor long-term prognosis (Wise, Cuffe, & 
Fischer, 2001, Crowley et al. 1998). This is very similar to findings among adults who were 
treated in either a mental health facility or a substance abuse treatment program (SAMHSA, 
2005). A common conclusion among practitioners and researchers is that working with 
adolescents who have a co-occurring disorder is more challenging than working with the 
child with only a mental health or only a substance abuse disorder (Rowe, Liddle, 
Greenbaum., & Henderson, 2004). At the beginning of the second decade of the 21st century, 
our understanding of co-occurring disorders among adolescents is still in its early stages. 
Much more needs to be done. Effective screening, assessment and effective treatment 
interventions are still in the future. 
3.2 Putting a face on people with a co-occurring disorder 
The typology presented here is based on intake data on more than 38,000 adult men and 
women who were assessed during intake or who were assessed and treated by 28 model 
agencies and four (4) control agencies between 2005 and 2008 in Oklahoma, U.S.A. This 
epidemiological study was one component of a state COSIG project to improve services for 
people with a co-occurring disorder. A focus group of professionals who were actively 
involved with treating people with a co-occurring disorder were recruited to help validate 
and refine the typology developed from this data.  
To provide adequate treatment and services, knowing the prevailing rate of people with a 
co-occurring disorder is essential for any behavioral health service system (McGovern, Xie, 
Segal, Siembab, & Drake, 2006). Agencies need data on the prevalence so as to better allocate 
scarce resources. This includes, developing clinical and staff trainings on using “best 
practices” and developing other support services that will reduce the high rates of treatment 
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failure and relapse among people with a co-occurring disorder. Additionally, Drake and 
others (2005) have asked that research in the future investigate and refine interventions; and, 
that researchers continue to clarify a typology of people with co-occurring disorders. The 
following analysis provides a typology of people who were admitted for treatment with an 
indication of a co-occurring disorder.  
3.3 People with a co-occurring disorder differ in many ways 
When a clinician meets a person with the co-occurring disorders of mental illness and 
substance abuse at admission, people with a co-occurring disorder will probably have many 
of the following characteristics. One of the overarching impressions, based on these data is 
that people with a co-occurring disorder have more in common with each other than they 
do with people who seek treatment for only a mental health or an addiction disorder. As a 
group they are different in many important ways.  
There was a difference in the percentage of people identified as having a co-occurring 
disorder between the model programs (defined as co-occurring treatment capable) and the 
control programs providing typical treatment. Model Program staff, over three years, 
identified approximately 38% of their clients as having an indication of a co-occurring 
disorder. The Control Programs identified discernibly fewer people as having a co-occurring 
disorder over the same period (average = 22%).  
3.3.1 Differences by gender 
Over the three years of data collection, there was only a slight change in the gender of those 
admitted to the model and control programs. As would be expected, there were more males 
admitted for treatment for a co-occurring disorder than females. Albeit, only slightly more 
males (52%) than females (48%) were admitted for treatment to the Model Programs. The 
Control Programs admitted slightly more females (53%) than males (47%). Men tend to be 
more challenging and defiant in treatment. The comprehensive training in treating people 
with a co-occurring disorder seems to have reduced staff resistance to treating men with 
more difficult behavioral problems. 
3.3.2 Differences in age  
There was no meaningful difference in age among people with a co-occurring disorder, and 
only a slight difference in the age of males and females. As a group, the age of men in this 
sample was approximately 36.5 years of age. Females with an indication of a co-occurring 
disorder were slightly younger (35 years of age). This appears to be a stable characteristic of 
people with a co-occurring disorder admitted to treatment in Oklahoma. 
3.3.3 Difference in education 
Education is important because one needs a minimal level of education to able to benefit 
from most treatment models. In these data, there was no significant difference in education 
between males with an indication of a co-occurring disorder and males without an 
indication of a co-occurring disorder. Women, however, with an indication of a co-occurring 
disorder had slightly less education than women without an indication of a co-occurring 
disorder. Educational levels tend to be a stable characteristic. Among men there is no 
significant difference in education. Conversely, women with a co-occurring disorder had 
slightly less education than women without an indication of a co-occurring disorder. 
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3.3.4 Difference in income 
Income can be a determinant in treatment effectiveness. The average yearly reported income 
for all men ($7,358, U.S, Dollars) admitted to treatment was slightly higher than all women 
($6,562, U.S, Dollars) admitted for treatment. The per capita income in the community 
where these people with a co-occurring disorder resided in 2008 was $38,415, U.S. Dollars. 
Clearly, co-occurring disorders that reach a level of severity that need treatment sorely 
interferes with an individual’s ability to support themselves or a family.  
3.3.5 Differences in homelessness 
When a co-occurring disorder is so severe it interferes with one's ability to earn a living the 
repercussions can be devastating. Both men and women with an indication of a co-occurring 
disorder are at risk of becoming homeless. In this sample, 8% of people entering a treatment 
facility were homeless. Of the 6,300 people who were homeless, 2,960 (47%) of the homeless 
were individuals with an indication of a co-occurring disorder. Of these homeless individuals 
with an indication of a co-occurring disorder, 65% were male and 35% were female. About half 
of the homeless individuals entering treatment will have a co-occurring disorder. Men with an 
indication of a co-occurring disorder who are homeless will outnumber women who are 
homeless with a co-occurring disorder by 2 to 1. More intense case management services will 
be needed when a person with a co-occurring disorder enters treatment as a homeless person.  
3.3.6 Differences in admission status 
Admission status is important when designing a treatment plan in mental health and 
substance abuse treatment. In this study, the group of people with a co-occurring disorder 
had significantly fewer ‘voluntary admissions’ among men and women with an indication of 
a co-occurring disorder than people admitted for treatment without a co-occurring disorder. 
More men and women with an indication of a co-occurring disorder were admitted by 
‘court commitment.’  More men and women with an indication of a co-occurring disorder 
were also admitted with ‘emergency detention orders’ (See Table 1).  
 
Voluntary Admissions NO COD  COD 
Men 64% 34% 
Women 75% 25% 
Civil Commitment NO COD COD 
Men 45% 55% 
Women 70% 30% 
Emergency Detention NO COD COD 
Men 47% 53% 
Women 60% 40% 
Table 1. Admission Status 
One can expect fewer men and women with an indication of a co-occurring disorder to be 
admitted voluntarily. Both men and women with an indication of a co-occurring disorder 
are likely to be admitted with some form of detention order. Both men and women with an 
indication of a co-occurring disorder are more likely to come into treatment as a result of 
legal intervention.  
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3.3.7 Difference in domestic violence 
There was no significant difference among women diagnosed with a co-occurring disorder 
and women with only a mental health or addiction disorder in terms of domestic violence. 
Over 44% of women admitted for treatment in any facility where data was gathered 
reported having a history of domestic violence. Over 10% of women in this sample reported 
being battered while pregnant. Among the women on which we have data, 3.5% reported 
that they were the perpetrator of the domestic violence that they were involved in. 
Among women admitted for treatment during the four years of this study, the rate of 
domestic violence tended to be similar year after year. The number of women reporting a 
history of domestic violence was stable over the four years of this study. As well, the 
number of women reported being battered while pregnant also remained stable over the 
four years of this study. In the professional literature researchers assert that domestic 
violence rates are higher among women with a mental illness or any substance misuse 
disorder than among women without significant behavioral problems. In the U.S. 
population at large, over their lifetime, 25% of women experience domestic violence (Tjaden, 
& Thoennes, 2000). The findings about the extent of domestic violence, in this study, are in 
line with the professional literature. In this study, domestic violence was over 50% higher 
among women entering treatment than women in the general population. 
3.3.8 Difference in arrest history 
A history of being jailed for behavior related to a mental illness or addiction is slightly more 
common for people admitted to treatment for a co-occurring disorder than people with only 
a mental illness or an addiction. Men and women with an indication of a co-occurring 
disorder were arrested more often 30 days before admission (2% were arrested) than men 
and women with no indication of a co-occurring disorder (1.2%).  
3.3.9 Difference in people identified with a serious mental illness 
At admission 66% of adult men and 68% of adult women in this sample were assessed as 
being seriously mentally ill. At discharge, 64% of adult men and 67% of adult women were 
assessed as still being seriously mentally ill. Within this group of women assessed as having 
a serious mental illness, 29% were also identified as having a co-occurring disorder. This is a 
ratio of 1 to 3.4 or 1 woman with an indication of a co-occurring disorder for every 3.4 
women assessed as having a serious mental illness. n this group of men with a serious 
mental illness 41% also had an indication of a co-occurring disorder. This is a ratio of 1 to 2.4 
or 1 man with an indication of a co-occurring disorder for every 2.4 men identified as 
seriously mentally ill.  
3.3.10 Difference in GAF scores 
The Global Assessment of Functioning (GAF) scale used in the mental health field is a 
numeric scale where zero (0) indicates the poorest level of functioning and 100 equals the 
highest possible level of functioning. It is a common behavioral health scale used by mental 
health clinicians and physicians in the United States. In the DSM-IV TR, it is described as a 
subjective scale to rate the social, occupational, and psychological functioning of adults. The 
range of scores reflects how well one is meeting various problems-in-living.  
Men and women in this sample identified as having a co-occurring disorder were given 
significantly lower/worse GAF scores than men or women with no indication of a co-
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occurring disorder. At discharge, nonetheless, there was no significant difference in the GAF 
score between people with an indication of a co-occurring disorder and those with no 
indication of a co-occurring disorder. This finding implies that, at least while in treatment, 
people with a co-occurring disorder (based on the judgment of clinicians) improved 
significantly. 
The average GAF score for a person with no indication of a co-occurring disorder was 
significantly higher; the person was healthier (No COD GAF = 47, COD GAF = 41). At 
discharge, there was little or no difference in the GAF score between people with an 
indication of a co-occurring disorder and those with no indication of a co-occurring disorder 
(No COD GAF = 50.72, COD GAF = 49.45).  
3.3.11 Differential DSM-IV TR diagnosis by discharge type and gender  
Substance Use Spectrum Disorder:  Over the four years of the study, on average 60% of men 
and women with an Axis I diagnosis of a substance use spectrum disorder completed 
treatment, while 18% left Against Clinical Advice (ACA).  
Psychoses Spectrum Disorder:  Approximately 68% of men and women with a psychoses 
spectrum disorder completed treatment. About 12% left ACA. 
Mood Spectrum Disorder:  In this group of men and women with an Axis I diagnosis of a 
mood spectrum disorder, 55% completed treatment; 20% left ACA. 
Anxiety Spectrum Disorder:  Among the men with an Axis I diagnosis of anxiety spectrum 
disorder:  22% completed treatment; 40% left ACA; 15% were administratively discharged. 
Women with an Axis I diagnosis of anxiety spectrum disorder did slightly worse in 
treatment; 20% completed treatment, but 44% left ACA.   
Undeniably, the people in this treatment sample seeking mental health or substance abuse 
treatment and who were diagnosed with an anxiety spectrum disorder, were failing in 
treatment. This could be an anomaly, but the emotional and financial burden on both the 
individual and society is unacceptable. There is a critical need to investigate treatment 
effectiveness and outcomes of people in other settings who seek treatment for an anxiety 
spectrum disorder. 
3.3.12 Discharge type among people with a co-occurring disorder and without a co-
occurring disorder 
Notwithstanding, the reality that completion of treatment at a treatment facility does not 
ensure long-term recovery; as well, leaving treatment ACA does not ensure relapse and 
readmission, men and women with an indication of a co-occurring disorder in this study 
tended to complete treatment more often and leave less often ACA.  
Both men and women with an indication of a co-occurring disorder completed treatment 
significantly more often and left treatment ACA less often than people with no indication of 
a co-occurring disorder. These findings defy conventional wisdom and the impression of 
many practitioners and researchers that people with a co-occurring disorder are more 
difficult to treat than people with a single disorder of mental illness or addiction. In fact, 
both conditions may be accurate. People with a co-occurring disorder that enter treatment 
are serious about obtaining treatment for their disorders and so they persist in treatment 
and do complete treatment hoping that they will be able to overcome their mental health 
disorder and addiction. Despite their efforts, however, treatment for co-occurring disorders 
is less than effective and long-term positive outcomes tend to be dismal at best and harmful 
at worst (See Table 2). 
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Discharge Type Completed Treatment Left ACA 
Men No COD 44% 30% 
Men COD 62% 16% 
   
Women No COD 38% 35% 
Women COD 58% 20% 
Table 2. Discharge Status 
4. Moving science to service 
Moving scientific discoveries to service, in a way that is sustainable, is more about changing 
the organization than it is about the science or the services provided. To describe how these 
scientific discoveries made their way into practice, the COSIG project, a SAMHSA initiative 
carried out in the United States between 2002 and 2011 can be used as a case study. In this 
construct, a logical role for a federal agency like SAMHSA is designing and funding 
programs to move science to service. The Annapolis Coalition report on the Behavioral Health 
Workforce, in the Executive Summary of that report (published by SAMHSA) entitled, An 
Action Plan for Behavioral Health Workforce Development delineated the problems caused by 
the 10 year lag time between the validation of an intervention and its use in the field (Hoge, 
et al. 2007). 
To conceptualizing the why and how changes occurred, we begin with the knowledge that 
the COSIG Project was designed as an intentional change effort with specific goals and 
objectives. These goals and objectives were linked to measures and preferred outcomes that 
could be used and compared to observed changes. Moreover, using this approach, it was 
also possible to identify the tools (events, activities, and initiatives) used by the 
implementation teams in their attempt to make changes in these complex, large 
organizational systems and agencies that provide mental health and addiction treatment 
services.  
In 2002, SAMHSA released a landmark report to Congress on Co-occurring Disorders that 
suggested a model of integrated services and treatment that was showing unprecedented 
success in the treatment of people with co-occurring disorders. The report and the 
subsequent money appropriated by Congress set the stage for the SAMHSA program called 
COSIG. The Congressional appropriation was used to provide funding, leadership, and 
support for state efforts. The COSIG project provided a one-time grant to fund States that 
wanted to develop or enhance their infrastructure to increase their state’s capacity to 
provide accessible, effective, comprehensive, coordinated/integrated, and evidence-based 
treatment services to persons with co-occurring substance abuse and mental health 
disorders. The COSIG project was funded for 10 years (2002-2011) (Center for Substance 
Abuse Treatment, 2007). 
4.1 Definition of evidence-based treatment 
Practices and treatments in behavioral health that have been shown empirically to have 
statistically significant better outcomes are identified as Evidence-based Practice (EBP) and 
Evidence-based Treatment (EBT). For the professional organizations of behavioral health 
practitioners (e.g., American Psychological Association, the American Occupational Therapy 
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Association, American Nurses Association, the American Physical Therapists Association, 
and comparable organizations internationally) have made EBP not just a recommendation, 
but a practice requirement based on ethical principles. 
Opponents of designating EBP interventions as the only acceptable standard for 
professional practice argue that all hard scientific evidence may not be applicable in real life. 
Knowing what a tested medication can do is entirely different from knowing what method 
works with an individual with a behavioral health issue. Treatment effectiveness depends 
on a host of ancillary factors, not the least of which is therapist’s style, personality, and 
training (Thomas & Pring, 2004). 
As demonstrated in this instance, moving science to service is a complex and laborious 
process. Changing large and even small organizations can be difficult, problematic, and 
even awkward. By nature, organizational change creates anomie within the organization. 
One of the responses to anomie (caused by the threat of change) is resistance from staff and 
administrators. Resistance to change from clinicians can be countered by presenting the 
science behind the need to change. Much more difficult, is resistance among administrators 
and bureaucrats. Although it sounds crude, more money and threat of job loss are the 
primary motivators for administrators and bureaucrats. If resistance cannot be assuaged, 
efforts to make positive changes will likely fail. 
A metaphor that might help in understand how change occurs in large institutions such as 
SAMHSA and state health departments (as well as other government institutions, 
corporations and conglomerates, universities, and mega non-profit corporations) come from 
watching supertankers (Ultra-Large Crude Oil Carriers that weigh-in at 625,000 tons when 
full) navigate the Atlantic Ocean off the coast of Florida. Fundamentally, these institutions 
are indistinguishable from supertankers in terms of the energy and time it takes for them to 
make a significant course change. A friend whose fishing boat went down between South 
Florida and the Bahamas told of seeing one of these monster tankers coming toward his life 
boat. As it approached, the crew of the supertanker who had spotted him waved and 
shouted to him words he could not understand over the noise of the tanker. As it passed by, 
without even slowing down, he told me that he thought they had probably radioed the 
Coast Guard. As the supertanker disappeared over the horizon he said he began to lose 
hope of being rescued; he was only a speck in the ocean somewhere in the vast Bahamas 
triangle. He could not figure out why the crew of the supertanker had not stopped to pick 
him up. Then several hours later he again saw a supertanker coming from the other 
direction. It was the same tanker coming back for him. It had taken hours for the tanker to 
slowdown and miles of ocean for it to “come about”. At a speed of about five knots it 
slowed enough to pick him up. Several hours later, after another slow looping turn, the 
tanker was back on course. It takes an excruciatingly long time to change course on these 
supertankers or in large institutions.  
5. International co-occurring initiatives 
While there was a concerted effort in the United States to develop and implement services 
for people with a co-occurring disorder, parallel initiatives were going on internationally. 
Even though, research and program development had a great deal more funding in the 
United States, countries around the world developed manuals, reports, and resource 
materials with recommendations for assessing and treating people with a co-occurring 
disorder. By the year 2000, funders and program planners globally had recognized that the 
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number of people with co-occurring disorders was much larger than they had thought and 
that treatment failure rates were extremely high. This was especially true in countries where 
mental health and substance abuse treatment costs were a substantial part of the national 
GDP. As the evidence grew about the rate of treatment, failure among people with a co-
occurring disorder, the excessive and often wasted cost of treatment became a widespread 
political concern. 
To make the point about the international response to the findings from epidemiological 
studies in different countries that the number of people with a co-occurring disorder was 
larger than had been known, events in Australia, Canada, and the United Kingdom will be 
briefly reviewed. What becomes evident from an international perspective is the scientific 
process was used by each country to study the problem. First, the majority of countries did 
an epidemiological study to identify the number of people who needed treatment. After 
establishing the need, groups of experts were organized to identify and recommend 
effective treatment approaches.  
5.1 Australia 
Early on, Australia was studying prevalence rates for people with a co-occurring disorder 
served by a vibrant addiction and mental health treatment community (Croton, 2004). In 2001, 
researchers also collected data on the overall prevalence of any mental health, substance use, 
and co-occurring disorder found among inmates in Australian prisons, one of the first studies 
of its kind. The prevalence of inmates with a mental disorder was 42.7%. The prevalence rate 
for any substance misuse disorder was 55.3%. With the exception of alcohol use disorders, 
women inmates had higher rates than men of mental illness and substance use disorders. The 
prevalence of a co-occurring mental illness and substance use disorders in the previous 12 
months was 29% (46% among women vs. 25% among men). There was a significant 
association between cannabis use disorders and psychosis in men, but not women. There was 
also a significant association between affective disorders and co-occurring alcohol use 
disorders in women but not men (Butler, Indig, Allnutt & Mamoon, 2011). 
In Australia, alcohol and drug treatment services and mental health services are 
administered and funded separately. Similar to organizational structure in other countries, 
separate funding lines provided little or no incentive for collaboration between the two 
groups of service providers. Previous national initiatives and funding schemas had 
attempted to minimize barriers to treatment and build strong partnerships between 
substance abuse treatment and mental health treatment practitioners. Nevertheless, a report 
by the Australian Institute of health and welfare in 2005 reported that despite previous 
efforts, people with comorbidity were still not being well served in Australia. 
In the 2003–04 Federal Budget, the Australian Government allocated funding for the 
development of the National Comorbidity Initiative to improve service coordination and 
treatment outcomes for people with coexisting mental health and substance misuse 
disorders. One priority area for action under this initiative was to improve data systems and 
methods of collecting data within the alcohol and drug treatment facilities, and mental 
health agencies in Australia (AIHW, 2005).  
5.2 Canada 
When researchers and experts in mental health and substance abuse treatment in Canada 
realized that a large segment of the treatment population in both sectors had a co-occurring 
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disorder, the next issue was to examine treatment outcomes. As suspected, neither mental 
health treatment nor substance abuse treatment facilities in Canada provided optimum 
treatment. Supported by this information, attention turned to the treatment community's 
capacity to providing co-occurring services.  
In 2000, the Canadian Minister of Health authorized Health Canada, a department of the 
Minister of Health, to form a working group and select a panel of experts from across 
Canada to synthesize best practice guidelines for providing treatment and services to people 
with a co-occurring disorder. The Canadian department was responding to the growing 
recognition that parallel or sequential treatment (treatment at two different facilities; one 
providing mental health services and the other providing substance abuse treatment) had 
failed. The panel of experts who identified best practices for this Canadian publication, 
recommend integrated treatment (integrated mental health and addiction treatment 
approaches) as a best practice in the treatment and care provided people with a co-occurring 
disorder (Centre for Addiction and Mental Health, 2002). It was a major step forward when 
the Canadian Minister of Health, in 2002, published the results of the work of the expert 
panel in the form of a monogram of resource materials and best practice assessment and 
treatment approaches that could be used to improve treatment and services for Canadians 
with a co-occurring disorder. 
In the monogram entitled, Best Practices: Concurrent Mental Health and Substance Use Disorders 
(Centre for Addiction and Mental Health), research findings to that point were updated and 
synthesized, and specific recommendations were made for screening, assessment, and 
treatment in an effort to improve treatment outcomes for people with a co-occurring 
disorder. A national inventory of specialized concurrent disorders programs, entitled 
National Program Inventory - Concurrent Mental Health and Substance Use Disorders was also 
developed and published as a companion document. The monogram was written for 
managers and staff of mental health, substance abuse and integrated mental health and 
substance abuse service agencies. In addition, it provided micro level information and 
recommendations that practitioners in the community who were tasked with providing 
quality service to people presenting with concurrent mental health and substance use 
disorders could use in their practice (Centre for Addiction and Mental Health, 2002).  
5.3 United Kingdom 
Little was known in the United Kingdom about the prevalence of people with co-occurring 
disorders in 1997 when Virgo and associates (2001) set out to establish the baseline numbers. 
Inspired by research conducted in the United States (e.g., Kessler et al. 1996; Regier et al. 
1990) up to that point, British studies had been limited to inner city London or to small 
groups of seriously mentally ill individuals. Moreover, the focus of the studies was on 
substance misuse and consumption rather than on prevalence or consequences (Menezes, 
1996). This non-metropolitan United Kingdom study conducted by Virgo and associates was 
the first to establish the lifetime and point prevalence of substance abuse and dependence 
among all current seriously mentally ill patients of all branches of the National Health 
Services (NHS) Trust, not just those with psychosis.  
The number of NHS patients with co-occurring disorders, at the time, was slightly smaller 
in this United Kingdom study than previously reported in the United States. Nonetheless, 
the findings related to consequences and characteristics of those with a co-occurring 
disorder were similar to that reported in the United States. In this study, 12% of the NHS 
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patients were identified with an adult mental illness, 12% met criteria for a substance abuse 
or dependence disorder, and 20% of those surveyed presenting with a serious mental illness 
were identified as having a co-occurring disorder. These percentages vary, however, 
depending on the service sector of NHS. The lowest percentage of those identified with a co-
occurring disorder (10%) was found among people receiving rehabilitative services. Taking 
into consideration the need for rehabilitative services among people with a co-occurring 
disorder, 10% seems to be rather low. On the acute wards, the percentage of people with a 
co-occurring disorder was as high as 41%. Compared to other patients in the study, those 
with a co-occurring disorder were younger, were more often male, lived in less stable 
accommodations, were unemployed, and had more than one psychiatric diagnosis. They 
tended to report more crises in their life, more abuse by others, were a greater risk to 
themselves and others, and reported more alcohol and drug involvement. The drugs of 
abuse reported by co-occurring patients identified as having an adult mental health disorder 
were alcohol and cannabis. In the group of patients being treated for addiction, who are also 
identified as having a co-occurring problem, the preferred drugs were heroin and alcohol 
with a co-occurring depression (Virgo et al., 2001).  
Once the prevalence rate among NHS patients was determined, research to identify the best 
approaches for training mental health teams to treat people with a co-occurring disorder 
began in the late 1990s. The result of this combined effort was the Pan-London 
Dissemination Project. This program was a “train the trainer” initiative designed to 
disseminate information on assessing and treating people with co-occurring disorders 
(Croton, 2004).  
They were also similar initiatives and efforts in other countries to address the needs of their 
citizens with a co-occurring disorder. Informed by the extensive research in the United 
States, Germany (Hintz & Mann, 2006), Russia (Mathew et al., 2010), New Zealand (Scott et 
al., 2008) and other countries followed a similar path in their efforts to provide effective 
treatment and services for their people struggling with the co-occurring disorders of mental 
illness and addiction. 
6. What if the two fields of practice are NOT compatible 
In the history of science there are few if any examples of convenient solutions that were 
effective and efficient. Programmatically, Integrated Treatment was the easiest next step 
after Parallel and Sequential treatment models failed to improve outcomes for people with a 
co-occurring disorder. The fallacy or inconvenient truth in the way integrated treatment was 
conceptualized (as many practitioners pointed out on a blog called the dualdx listserv in 
2006-07) the consensus among experts who focused on co-occurring disorders was that the 
treatment interventions from both treatment traditions were compatible—capable of 
existing or performing in a harmonious way with one another.  
This is a critical assumption. What if the two treatment models are not compatible?  What if 
they work in opposition when combined?  What if integrating the two models of treatment 
is like trying to merge two partly dysfunctional systems?  What if philosophically we are 
trying to do the equivalent of mixing oil and water?  What if parallel and sequential 
treatment failed not because of the specific timing of deployment of the treatment types, but 
because they work one against the other when combined?  For illustration purposes, what if 
the two treatment approaches are like many medications that cannot be taken together. 
These possibilities create a dilemma for clinicians, program developers, and funders. If 
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neither technology nor a combination of both technologies are effective in treating people 
with a co-occurring disorder—what other technology is available?   
The answer to the first question, in my view, is that the two treatment modalities are not 
compatible and they cannot be integrated effectively unless treatment philosophies and 
policies in both fields are willing to change. Neither field has developed a set of treatment 
interventions sufficient to recommend either of them in whole.  
The answer to the last question—rather than integrate the two systems of mental health and 
addiction treatment in whole, I would argue that an applied research approach be used to 
carefully select the best components from each field and weave them into a new and third 
technology. Pursuit of a synthesis of the best practice components in and of itself would go a 
long way in the development of a more effective and efficient treatment modality. During 
this process, it will be critical to identify best practices treatment approaches, interventions, 
and techniques that work and promote wellness for people in treatment. It will also be 
critical to identify, consciously discard, and then disseminate information on treatment and 
services that are ineffective, inefficient, and/or produce poor outcomes. Clinicians in the 
Behavioral Health related fields should be held responsible for disclosing information about 
their interventions in the same way that drug companies are supposed to reveal the side 
effects and negative outcomes of the treatments they sell.  
To start this process, I recommend that clinicians discard the paternalistic attitudes endemic 
in mental health treatment (e.g., Angell, 2006; Sowers, 2005; Lefley, 1998). I also recommend 
that the punitive approach also referred to as the conformational approach that has been one of 
the distinguishing characteristics of substance abuse treatment be discarded as brutish 
because it does not meet the standards that define best practices (e.g., Quinn, Bodenhamer-
Davis, & Koch, 2004; Dongier, 2005).  
6.1 Paternalism is NOT Treatment 
Clinicians in the field of mental health for the most part have a paternalistic orientation 
toward their “patients.”  They are trained in subtle ways to see a person with a mental 
illness as totally and permanently disabled. Moreover, paternalism among clinicians has a 
long and rich history. 
Clinicians and mental health programs with a paternalistic orientation have few and limited 
expectations of people with a mental illness, other than the patient following the “doctor’s 
orders” and being compliant (Sowers, 2005). By way of example, the perception of 
permanent disability is so ingrained the science and knowledge of mental health that the 
concept of recovery (a major part of the treatment for addiction) was not included into the 
mental health model of treatment until after mid-2005.  
The hebetude that results from paternalism in mental health gone awry is a legacy of our 
past. When paternalism was the core of the clinical response to mental illness, people with a 
mental illness were locked away in mega mental hospitals in the United States for their care 
and protection. This approach to care and treatment, often referred to in modern times as 
milieu therapy, caused a secondary disorder where the resulting mental and physical 
lethargy was accurately named, “institutionalization” (Lamb & Oliphant, 1978). 
The attitude of those in the mental health treatment community after the 1840’s in the 
United States was that they were responsible for the care and treatment of people with a 
mental illness. In fact, the charge to the Superintendents of American Asylums in the late 
1800s was to care for the physical and mental needs of those with a mental illness and to 
protect the public (Hurd, 1916).  
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This “care model” resulted in institutional behavior. Institutionalization is an adaptive 
behavior by people to survive in a situation where pervasive institutional controls result in 
the mental, emotional, and behavioral characteristics of learned helplessness (Lunt, 2004). 
Institutionalization of people with a mental disorder became ubiquitous after the American 
public asylum movement (started in the 1840s) degenerated into mega public mental 
hospitals where patient management, administration, and financial concerns replaced 
treatment and rehabilitation.  
In the second half of the 20th Century, the attitude of many mental health practitioners 
toward patients and clients has been shaped by an illness perspective (Beers, 1909; Sowers, 
2005). Cynical in nature, in part because of the legal pressure as a result of the 
“deinstitutionalization movement” in the 1970s, the “illness perspective” rationale went 
something like, ‘Even though most people with a mental illness would be better off in a 
hospital, it does not mean that he or she has to be confined to a hospital to receive 
treatment.’  Today practitioners are in agreement that a person with a mentally illness has as 
much right to be in the community when they are stable as anyone else (Lunt, 2004). A 
concept we can support; but a concept that is extremely difficult to operationalize using 
symptomatology. In particular, the term stable is difficult to operationalize when the 
influence of culture on behavior changes symptomatology that defines a diagnosis.  
Although wrought with problems, the illness perspective created a climate that viewed 
institutional care as one of several levels of care including outpatient care. Nevertheless, one 
of the underlying messages to people with a mental disorder is that they are being 
supervised as much as treated by the clinicians who represent a rigid and intractable mental 
health treatment community. Services and treatment provided in this atmosphere leave the 
people being treated for a mental illness with little hope, power, or vision of what life will be 
like if their symptoms have diminished (Grenville, 2001).  
Too often, one of the consequences of a therapeutic intervention for a person who is being 
treated for a mental disorder by paternalistic clinicians is the message it conveys. The message 
reinforces a belief on the part of the clinician and the person with a mental disorder that 
people with a mental disorder have a lifelong mental impairment that will always need care 
and treatment by professionals in the field of mental health. The more recent development of 
the ‘community model,’ as a way of providing mental health services outside of institutions 
and facilities has turned out to be merely another ‘care model’ that institutionalizes and makes 
helpless the people the system is trying to rehabilitate (Lunt, 2004). By including the concept of 
“recovery” as it is understood in the addiction field, in the treatment of people with a co-
occurring disorder, the therapeutic message is exactly the opposite from the message 
conveyed by a paternal philosophy (Becker, Drake, & Naughton, 2005).   
Practitioners in the field of medicine have a different view of treatment and care when it comes 
to physical injuries and illnesses. In the medical field, when a person has another episode or 
relapse with a medical problem, treatment is often required, but the person is expected to 
recover and continue on with their life. Similar to breaking a leg, surgery, or cancer, the 
expectation of practitioners and those with a co-occurring disorder should be that they will 
recover and resume their life as a student, an employee, an artist, an engineer, a mental health 
clinician, and so forth. All interactions and treatments need to be based on the expectation that 
the person will recover and resume or become engaged in a productive life.  
Taking all this into consideration, there is little doubt that practitioners in the mental health 
field clearly differ from clinicians in the substance abuse treatment community on the issue 
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of “personal responsibility” (Wing, 1995). For better or worse, at least substance abuse 
counselors hold their clients accountable for their behavior even if the tools that substance 
abuse counselors offer are often useless. Counselors in mental health have little or no 
expectation of their clients, even when the tools they offer can be quite helpful in reducing 
symptoms associated with a mental illness (Lunt, 2004). 
6.2 A punitive attitude and confrontation are NOT treatment 
Since the late 1950s, what is known as traditional substance abuse treatment for the indigent 
and chronically addicted has been residential treatment that varied far from the clinical 
treatment path. For instance, if you walked onto a traditional Therapeutic Community, you 
would likely see a resident walking around wearing a diaper over his/her clothes with an 
oversized pacifier around his/her neck with a sign on the person’s back reading, ‘I won’t 
grow-up.’  Outside in the court yard you could very well see a woman with a shaved head 
digging a hole three feet deep and placing a penny at the bottom of the hole, filling in the 
hole and then digging the penny out again. These types of degrading punishments, called 
therapeutic intervention are used to demonstrate to the addict the fruitlessness of their 
addictive behavior. Similar castigation is called therapy in hundreds of Treatment 
Communities in the United States. States and the Federal government pay millions of 
dollars each year to Treatment Community programs to provide this type of punitive 
treatment. Logically, if punishing and being callous to people who are abusing drugs was a 
cure for their misuse there would be no drug abuse anywhere in the world. If the punitive 
approach worked, there would be fewer people in prison for drug possession and use. 
Modern drug treatment, for all intent and purposes, began in the 1930’s with the 
development of Alcoholics Anonymous (AA) and AA’s use of the self-help group. AA and 
Narcotics Anonymous (NA) type self help groups use a non-judgmental passive approach. 
AA and NA members extend themselves to people who want help with their addiction. 
They do not compel a person to quit or give up their addiction. But, they support the person 
who is committed to overcoming their addiction. To its credit, over the years, many addicts 
have been helped by AA and NA. A large percentage of addicts, however, needed and 
continue to need more than AA and NA can offer. Because clinical treatment was expensive 
and admittedly not very successful, the next major change in the treatment of addiction was 
residential treatment provide by addicts in “recovery.”  The two best known programs are 
the Synanon model developed in the late 1950s and the Therapeutic Community model 
developed in the mid 1970’s (Janzen, 2001).  
The Synanon program and the Therapeutic Community (both closely related in philosophy 
and treatment) were a clear departure from the psychiatric and therapeutic treatment in 
general and specifically for the treatment of addiction. The Synanon and Therapeutic 
Community leaders largely rejected professional psychotherapeutic treatments with the 
exception of self-help groups. The preferred counselor was a recovering addict.  
6.3 The Synanon model 
The Synanon group started in 1958 in Santa Monica, California as a drug and alcohol 
rehabilitation program. Charles Dederich (1914 to 1997) the founder of Synanon gained 
national prominence for developing a program that could cure narcotic addiction. Not as 
well known is the reality that this treatment approach was not very successful and 
graduated few people who lived productive lives outside of the Synanon community. In 
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1967, Synanon leadership abolished "graduation" and offered itself as an alternative-lifestyle 
community. Later it became the Church of Synanon (Janzen, 2001; Yates, 2003). 
By 1977, Synanon was being referred to as a cult that controlled members using what was 
called the "Synanon Game."  A pseudo therapeutic approach, the “Synanon Game” involved 
members humiliating one another and being forced to expose their innermost weaknesses 
and fears. This was a distortion of the encounter group process. This approach is based on 
the premise that when challenged, people examine themselves and learn new ways of 
behaving (Kaplan & Broekaert, 2003).  
At its peak in the mid 1970s, Synanon women were made to shave their heads, married 
couples were forced to break up and take new partners, males were forced to submit to 
vasectomies, and a number of women who became pregnant while living in the community 
were required to have abortions (Yates, 2003). 
What began as a highly praised drug treatment program, ended when Synanon leaders 
became implicated in an attempted murder. Synanon was closed in 1991 because of 
megalomania and financial problems brought on by lawsuits and disputes with the Internal 
Revenue Service over its nonprofit status (Janzen, 2001).  
This was not the end, however, of Synanon’s influence. Programs based on the Synanon 
model sprang up across the United States for adolescent drug users. First called the “Seed,” 
this program later operated under names such as Straight Inc., Safe Recovery, Kids Helping 
Kids, Growing Together of Lake Worth, and Pathway Family. From 1976 to 1993 Straight, Inc. 
operated the world's largest chain of juvenile drug rehabilitation programs. They are 
reported to have treated as many as 50,000 adolescents. In 1974 the U.S. Senate "likened" the 
methods of The Seed to those used by North Korean brainwashers (ISCA, 2002). 
6.4 The treatment community model 
After being discredited, Synanon’s concept of community treatment inexplicably became the 
foundation for the residential treatment approach called the Therapeutic Treatment 
Community model. The punitive attitude and retaliatory consequences that defined 
Synanon treatment were carried over in great part as treatment interventions used by 
Therapeutic Treatment Community counselors. The philosophy is based on the notion that 
if an addicted person is harshly challenged, they will examine themselves and learn new 
ways of coping without the substance. To paraphrase a drug counselor, “We can make life 
so horrible that giving up drugs is the lesser of two evils.”  As many working in the field of 
substance abuse treatment, I have witnessed people in a Therapeutic Treatment Community 
treated worse than people in prison. You could not legally treat people in U.S. prisons like 
the people in Therapeutic Treatment Community programs are treated. Such treatment 
would be unconstitutional. 
To be fair, those who advocate for the Therapeutic Community model see the primary goal 
of a Therapeutic Treatment Community is to “foster personal growth.”  One accomplishes 
personal growth by “changing one’s lifestyle” this is brought about through a community of 
concerned people working together to help themselves and each other. The Therapeutic 
Treatment Community is designed to be a highly structured environment “with defined 
boundaries, both moral and ethical.”  Personal growth is promoted by “community imposed 
sanctions and penalties, as well as earned advancement of status and privileges,” which are 
perceived as “part of the recovery and growth process” (Charles & Eric, 2003). Hayton, 
(1998)defined a therapeutic community as a structured method and environment for changing 
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human behavior in the context of community life and responsibility (SAMHSA, 2006b). This 
sounds like a helpful and benign environment, but the description can also be used to 
describe a prison or jail.  
In spite of its history, there is a consensus among experts that using a Modified Therapeutic 
Community model for treating people with a co-occurring disorder can be beneficial. To be 
fair, those who advocate using a Modified Therapeutic Community model for people with a 
co-occurring disorder, do not recommend using confrontational approaches and provide 
services that allow co-occurring clients to access and take medication while in treatment 
(Skinner, 2005). 
The behavioral literature clearly differentiates between positive reinforcement and negative 
reinforcement, and punishment. The punitive approach has no place in the treatment of a 
person with a co-occurring disorder. The punitive approach does not come up to the 
standards of care proposed by SAMHSA in the publication, Co-Occurring Disorders: 
Integrated Dual Disorders Treatment Implementation Resource Kit (SAMSA, 2003a). As a 
component of a therapeutic milieu, the punitive approach has no empirical support. 
7. A third technology 
7.1 Why do we need a third technology?   
Why do we need a third technology?  We need a third technology for at least two 
compelling reasons. First, research consistently finds that mental health and substance abuse 
treatment, as they are practiced in 2012, are marginally effective. They are not efficient. 
Multiple relapse is the rule. The failure rate makes current treatment cost exorbitant. Second, 
as the brief history presented in this chapter again reminds us, the mental health and 
substance abuse treatment approaches are grounded in tradition, not in science. This is not 
to say that many of the interventions used in mental health and substance abuse treatment 
have not been tested. Most of the standard therapeutic interventions used have been 
investigated, some using the double-bind methodology. What is not included in the calculus 
when testing these interventions is the difficulty involved in testing the effectiveness of a 
traditional treatment technique. The influence of a tradition is subtle and affects the thinking 
of researchers and thus the formation of the research questions asked by the researchers. 
Without considering the history of the development of the two traditions, investigators and 
clinicians are at risk for thinking that the reason why specific interventions are used in 
mental health and addiction treatment is because they have met some standards such as 
“safe and effective.”  This could not be farther from the truth.  
Since the 1950s, we have continually tweaked these traditional approaches. And, with each 
tweak the traditional approach is found to be more effective. Yet, outcome studies do not 
confirm that these short-term treatment successes actually manifest themselves in long time 
successful outcomes. The research showing a lack of long-term success is particularly 
distressing. Especially, if you consider that success in treatment is distorted because 
expectations are already so low almost any outcome of treatment that is slightly above being 
a vegetable is considered a successful outcome by today's standards. 
A final argument would be philosophical. Using an analogy, I would compare efforts to 
continue to tweak the two traditions to make them seem to work better is similar to patching 
up an old rotten and a leaky roof. At some point, the roof is going to have to be replaced. 
There might be parts of the old roof that can be used in the new roof, but a point will be 
reached when the repairs cost more than replacing the roof. In the field of mental health and 
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substance abuse treatment, a growing cadre of practitioners and researchers believed that 
we have reached the point where something needs to change.  
Among the problems that I had when radically changing technology at a substance abuse 
treatment facility to treat people with a co-occurring disorder was changing the addiction 
culture. As one would expect, some staff resisted any change. They were committed to the 
tradition, especially those staff “in recovery” who were also counselors and clinicians. Staff, 
however, are at a disadvantage. Administrators and supervisors extend or withhold 
rewards to change behavior. This was not the case among clients who came for treatment, or 
for the community of AA members. Those two groups of people were as resistant, or more 
resistant to change than staff.  
7.1.1 No new treatment model has emerged 
Mixing oil and water is not a solution. A third technology needs to be developed. A new 
treatment model specifically designed to treat people with a co-occurring disorder is needed 
to replace the Integrated Treatment model. The contorted rationale that was used to integrate 
mental health and addiction treatment modalities to develop the integrated treatment model 
is so intellectually dishonest one has to suspend a sense of reality to even imagine that the 
two are compatible in practice. 
The panel of experts, involved in writing SAMHSA’s Tip 9 clearly recognized the 
incompatibility of the two treatment fields. Given their combined experience, they agreed 
that the conflict between the two treatment modalities was largely responsible for the failure 
to provide effective treatment for people with the co-occurring disorders of mental illness 
and substance misuse. They wrote: 
For people with dual disorders, the attempt to obtain professional help can be 
bewildering and confusing. They may have problems arising within themselves as a 
result of their psychiatric and AOD use disorders as well as problems of external origin 
that derive from the conflicts and clashing philosophies of the mental health and 
addiction treatment systems.  
Historically, when patients in AOD treatment exhibited vivid and acute psychiatric 
symptoms, the symptoms were either: 1) unrecognized, 2) observed but were described 
as symptoms of intoxication or "acting-out behavior," or 3) accurately identified, 
prompting the patients to be discharged or referred to a mental health program. 
Virtually the same process occurred for patients in mental health treatment who 
exhibited vivid and acute symptoms of AOD use disorders. (p.11) 
Yet, between the publication of Tip 9 and Tip 42, there was no reported work by the 
committee of experts on those two panels to address the issues of incompatibility. Even so, 
the panel of experts involved in the identification of interventions applicable to treating 
people with a co-occurring disorder continued to recommend integrated treatment. 
Basically, the recommendation was to combine the philosophies and techniques from each 
field and ignore their intrinsic differences. 
7.2 Selecting the best components from each field 
A limited number of variations on the Integrated Model promoted by SAMHSA have been 
proposed but no model proposed is based on deliberately selecting and discarding 
components from the interventions used to treat mental illness and substance abuse. All the 
same, even without this level of deliberation about interventions a number of addiction 
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treatment programs that simply modified their services to include psychotropic medication 
have shown improved outcomes when treating people with co-occurring disorders 
(SAMHSA, 2003c; Osher & Drake, 1996; Sacks et al., 1997; Sciacca & Thompson, 1996). 
7.2.1 Components that seem to be compatible 
 Clinicians from both fields are trained in the psychosocial model of behavior. 
 Clinicians from both fields see a need for a continuum of care which embraces the value 
of a variety of treatment settings and program types in both public and private settings. 
 Clinicians from both fields support the extremely important adjunct role played by self-
help organizations in both fields. 
 Clinicians from both fields accept case management and care management as an 
important component of treatment and care. 
 Clinicians in both fields see the value of peers or professionals with lived experiences as a 
critical support in developing and implementing an individual's care and support plan; 
 Genetic research to identify the cause of the behavioral disorder is important to both 
fields. 
 The evolving recipient of care movements that periodically influence change in the 
delivery of treatment services has affected both fields, most often in mental health.  
 The emerging professional perspective and training that gives a higher priority to more 
basic needs of food, shelter, clothing, work, friendship, etc. has affected the workforce 
issues in both fields;  
 The ever-increasing role of pharmacologic therapy in the treatment of substance misuse, 
moves substance-abuse treatment closer to the mental health perspective on treatment.  
 There is a growing recognition that family members and significant others, as a group 
may be in need of services themselves.  
 There is a potential for a common, or at least a convergent treatment modality for both 
fields.  
(SAMHSA, 1995, p. 14; Centre for Addiction and Mental Health, 2002, p. 70-71) 
There is an increasing recognition of the overlap in the population needing help and the 
expressed needs of consumers for better continuity of care within and across the respective 
systems. Hopefully this recognition will motivate scrutiny of treatment failure, relapse, and 
less than optimal long-term treatment outcomes. 
7.2.2 Components to discard  
A first step that would go a long way to improving the treatment and services provided 
people with a co-occurring disorder would be to decriminalize mental illness and addiction. 
The underlying threat of arrest and confinement if one does not comply with the treatment 
recommendations of one's illness undermines the best intentions of the mental health and 
addiction treatment practitioners.  
Clinicians in both fields rely too heavily on the correctional system for formal and informal 
social control. Forcing people into treatment, without it being absolutely necessary, results 
in resistance and defiance from the person designated with a mental health or substance 
misuse disorder. This should be replaced with a collaborative therapeutic and case 
management relationship. 
Confrontation is never acceptable. Even using less than a confrontational approach, what 
some resource material refers to as “being direct” may feel like abuse to the person in 
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treatment. Identifying and pointing out irrational thinking, based on the perspective of the 
clinician, can result in a conflict between the clinician and client. Insisting on random 
alcohol and other drug tests when working with people with a co-occurring disorder can 
reduce the level of trust and harm the therapeutic relationship.  
Consequences and contingencies are not therapeutic modalities. They belong to corrections 
and social control agencies. Making a person responsible for his or her behavior sounds 
good but when a person is responding to delusional thoughts, is this really being defiant?  
Should clinicians spend time keeping records of violations of rules?  Who does it benefit 
when clients are made to experience consequences of their behavior; the client who learns 
from being punished?  When is developing therapeutic insight less beneficial than breaking 
through denial?  
Stigma is often cited as a reason why individuals do not seek treatment from mental health 
providers or from substance abuse treatment facilities. The community at large is often cited 
as the source of stigma. As important as stigma in the community, is stigma among 
professionals in the field of mental health and substance abuse treatment. To reduce the 
stigma, professionals must first advocate for the rights of individuals seeking treatment in 
their own professional organizations. In a community context, advocates and professionals 
need to promote public education and understanding. As long as stigma remains high 
among clinicians, however, it will be nearly impossible to change the minds and attitudes of 
people in the community at large. 
Widespread use of residential treatment for substance misuse disorders and confinement at 
a mental health treatment facility needs to be radically curbed. This is a relic left over from 
the days of the asylum. Outpatient, day treatment, and self-help groups need to be better 
supported and expanded. 
The resistance to sharing power with the client in a therapeutic relationship by clinicians, an 
antiquated paternal attitude, renders treatment planning less effective and distorts 
therapeutic intentions.  
In the field of mental health, the reluctance of clinicians to work with paraprofessional with 
lived experience (people in recovery after experiencing a mental illness) denies clients a 
major source of understanding, empathy, and a view of a positive future for themselves and 
others who have suffered from a mental disorder. This also denies the clinician a positive 
view of people who have been treated for mental illness. 
Mandated treatment needs to be discarded. Treatment should be offered and available as a 
tool or resource to help the person reach their life goals.  
This is a short list and by no means comprehensive. This list will also grow and continue 
and expand as clinicians and researchers began to see people with a mental health and 
addiction disorder as people rather than people as their disorder. Disorders that too many 
clinicians believe need to be controlled and managed. Instead, when clinicians become more 
sensitive to the needs of people seeking treatment and view clients as living in a context 
normalized by ethnicity, culture, language, and education, both mental health and 
substance abuse treatment will become more effective.  
7.2.3 Components to keep 
The following is proposed as a starting point in the selection of the best treatment 
interventions from the mental health and substance abuse treatment fields. From the Mental 
Health treatment field we need to keep the knowledge of “symptomology” and information 
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about the course of a mental illness that has been developing since Moral Treatment was 
introduced by Philippe Pinel (1745-1826) and Jean-Baptiste Pussin (1745-1811) (Rousseau, 
1990). From the Substance Abuse treatment field we need to keep the philosophy and 
concept of “recovery” (Lunt, 2004). In the substance abuse treatment community, people 
receiving treatment for substance abuse are not thought to need treatment for the rest of 
their lives. Although, not needing continual treatment for the rest of their lives (like a person 
with a mental illness), clinicians working in substance abuse treatment, Alcohol Anonymous 
(AA), and Narcotic Anonymous (NA) believe that a person who was once addicted will 
always be an addict and will need to be in recovery mode for the rest of their lives. 
8. Synthesizing the two fields 
In addition to using Kuhn’s description of a “paradigm shift,” to explain the shift in 
philosophical and clinical assumptions to include treatment for people with a co-occurring 
disorder, the emergence of treatment philosophies and interventions can be described as a 
process of “thesis, antithesis, and synthesis” (this construct is often incorrectly attributed to 
Hegelian theory) (Plant, 1999). Professional treatment by licensed clinician’s could be 
thought of as the thesis. Treatment based on tradition derived from people who have 
experienced addiction could be the antithesis. The work of synthesizing the best 
components of the two fields can be used as an analytic tool in continuing the development 
of a third technology, a new model, perhaps simply called Behavioral Medicine.  
The Society of Behavioral Medicine offers a beginning definition:   
Behavioral Medicine is the interdisciplinary field concerned with the development and 
integration of behavioral, psychosocial, and biomedical science knowledge and 
techniques relevant to the understanding of health and illness, and the application of 
this knowledge and these techniques to prevention, diagnosis, treatment and 
rehabilitation. (http://www.sbm.org/about/definition.html)  
8.1 Consider a model using select components from both fields 
In the mental health and drug addiction treatment systems that I have been associated with 
and that I have evaluated, all too often it is not the service needs of the individual that drive 
the treatment system; it is the treatment system that drives and determines the treatment 
services available and ultimately provided the client. In the mid 1990s, an opportunity 
presented itself that allowed me to redesign a traditional Treatment Community model 
program so as to provide services and treatment for people with a co-occurring disorder. 
The treatment programming we developed (for lack of a better term, called the Sapient 
Model) combined empirically based practices with the best consensus based practices that 
were thought to be effective among people with a co-occurring disorder.  
Treatment started with an engagement model that included motivational intake 
interviewing, activities to develop and maintain a bond between the person seeking 
treatment and the staff, the other residents, and the program philosophy of recovery as 
defined by “Bill and Bob” in the “Big Book.”  Individual and group therapy was based on 
cognitive behavioral techniques. Treatment included individual and group work on 
developing and maintaining relationships, and developing and maintaining social supports. 
Services included education about co-occurring disorders, case management, outpatient 
treatment, and help with housing and employment. 
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Psychiatric services were introduced and psychotropic medications became a common 
component in the overall treatment plan. One practice that was extremely useful with 
residents was the policy of negotiating treatment with those who did not believe that they 
needed psychotropic medication or did not want to take it. They wanted to recover on their 
own. If the treatment team believed medication was needed, the psychiatrist, the clinical 
director, and the person’s individual therapist would meet with the resident and negotiate 
an agreement. Typically, it was an agreement that the person would not be asked to take 
medication, but if they relapsed, then they would work with the team and try medication if 
recommended to see if it helped.  
Programming policy did not allow “encounter groups,” “confrontational approaches,” or 
playing “the game” by staff or residents. The confrontation approach had been the primary 
form of treatment before the program was redesigned. The policy created much 
consternation among the Certified Addiction Counselors and the proponents of the 
traditional treatment community.  
This treatment community model intervention also called, “getting pulled-up” or “getting 
called on your s**t” can be extremely harmful. These approaches tend to encourage 
confrontation and punishment by counselors and confrontation between residents who can 
also call someone on their “s**t.”  This form of the treatment community life experience was 
replaced with a community experience of self governance. The Resident’s Council made and 
negotiated program policy with the staff and administration. They advocated for services 
and provided valuable community service to the neighborhood where the treatment 
program was located. 
Residents who broke rules were apprised of the consequences of their behavior and their 
responsibility for their behavior. The staff would determine appropriate consequences for 
the resident who broke the rules. This could range from housekeeping tasks, to starting 
treatment over at day one. If the person chose to accept the consequences, he or she would 
continue their treatment in the program. If the person chose to leave the program, he or she 
was asked to return to our treatment program when they were ready to resume treatment. 
Another program policy that was discarded because it was counterproductive was the 
policy of discharging people who relapsed while in treatment. Relapse was considered the 
same as breaking any of the rules. The staff would determine appropriate consequences for 
the resident who relapsed, but a relapse would not bar the person from continuing in 
treatment. It is difficult to treat a person who has been “kicked” out of the program. 
Another valuable policy encouraged residents who were discharged as a treatment success 
to return to our program for additional work on their recovery efforts if they relapsed. As a 
staff, we knew the person and believed that we would not have to start from square one. 
The typical policy among treatment community programs is that a resident who is 
discharged (whether they succeeded or failed) is not allowed to return to the program for 
any reason, even for a visit for at least one year. Obviously, this would keep people who 
failed treatment out of sight. 
A related policy gave each resident the right to belong to the Program’s alumni association. 
Everyone was asked to come back to the Program for monthly meetings.  
Another helpful policy related to facilitators who brought AA and NA meetings into the 
treatment center. They were required to accept people into meetings who took medication 
for psychiatric problems. As the clinical director, I also met with several AA and NA rooms 
that residents attended and asked that they to be more understanding of people from our 
program that were taking medication for a mental illness. 
www.intechopen.com
 
Mental Illnesses – Evaluation, Treatments and Implications 
 
220 
As a retention model, the success is supported by State and Medicaid data that show a 
retention rate of around 90% for the first 30 days over a continuous four year period. Long-
term success, however, was not as impressive as the engagement model. Long-term 
recovery was hampered by a lack of community support services available to residents who 
completed treatment. In many cases, the problem was obtaining and paying for expensive 
atypical psychotropics after the resident left treatment. A lack of programs to provide 
supportive housing and employment were also problematic. Even so, the recovery rate for 
residents, in the first year after discharge varied around 50% for residents over a three year 
period. 
More recently, in 2004, I had the good fortune to become the evaluator of the Oklahoma Co-
Occurring State Incentive Grant from SAMHSA. The grant supports efforts at the State level 
to integrate the mental health and substance abuse service systems. Analogous to my 
experiences, over the last 30 years, the knowledge base and conceptualization of treatment 
for people with a co-occurring disorder has evolved and continues to evolve. 
Given my experience at this point, if I were redesigning the program today, I would also 
incorporate knowledge about the stages of change in both residential and outpatient 
treatment. I would also promote the development of self-help groups for people with a co-
occurring disorder such as Double Trouble in Recovery, Dual Recovery and other self-help 
groups, both at the program level and in the community.  
9. Conclusion: An emerging treatment model 
The role played by SAMHSA using the COSIG project as a catalyst for a process that 
exposed both the strength, weaknesses, and points of philosophical incompatibility of the 
two traditions should not be underestimated even though it was probably happenstance. In 
particular, endorsing the Integrated Treatment model without addressing the differences 
and incompatible components in these traditional models created a crisis. This crisis 
although disturbing and creating havoc much like any major change, does give us the 
opportunity to rethink and realign concepts of treatment. Based on the accumulated 
knowledge from mental health and the treatment of addiction, and knowledge gained since 
the 1990s during a major effort to develop better treatment interventions for people with co-
occurring disorder, that knowledge is available to begin to develop a modern, scientifically 
based third technology specifically designed for people wanting treatment for a co-
occurring disorder.  
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